We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

44 hedge funds and large institutions have $150M invested in Mirati Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

7% more capital invested

Capital invested by funds: $140M → $150M (+$9.47M)

2% more funds holding

Funds holding: 43 → 44 (+1)

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
14
Reduced
13
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.14M
2
BFA
BlackRock Fund Advisors
California
+$474K
3
BI
Boulegeris Investments
Georgia
+$187K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$132K
5
Morgan Stanley
Morgan Stanley
New York
+$130K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$843K
2
Franklin Resources
Franklin Resources
California
-$489K
3
Goldman Sachs
Goldman Sachs
New York
-$158K
4
JP Morgan Chase
JP Morgan Chase
New York
-$72.9K
5
TRCT
Tower Research Capital (TRC)
New York
-$59.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$321K +$132K +7,859 +83%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$245K +$961 +57 +0.4%
UBS Group
28
UBS Group
Switzerland
$218K +$198K +11,760 New
BI
29
Boulegeris Investments
Georgia
$205K +$187K +11,075 New
Charles Schwab
30
Charles Schwab
California
$195K – – –
TA
31
Teachers Advisors
New York
$190K – – –
NFA
32
Nationwide Fund Advisors
Ohio
$100K +$1.99K +118 +2%
AIG
33
American International Group
New York
$83.5K -$3.02K -179 -4%
FANJ
34
Financial Architects (New Jersey)
New Jersey
$56K – – –
BA
35
BlackRock Advisors
Delaware
$50K -$4.6K -273 -9%
TRCT
36
Tower Research Capital (TRC)
New York
$38K -$59.5K -3,529 -63%
Citigroup
37
Citigroup
New York
$23K +$16.5K +981 +392%
Wells Fargo
38
Wells Fargo
California
$19K +$51 +3 +0.3%
Barclays
39
Barclays
United Kingdom
$10K +$5.85K +347 +147%
AllianceBernstein
40
AllianceBernstein
Tennessee
$7K – – –
Northwestern Mutual Wealth Management
41
Northwestern Mutual Wealth Management
Wisconsin
$7K +$6.74K +400 New
Creative Planning
42
Creative Planning
Kansas
$5K +$4.35K +258 New
BRWM
43
B. Riley Wealth Management
Tennessee
$1K – – –
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$57 -$8.39K -498 -14%
SO
45
STRS Ohio
Ohio
– -$42K -2,400 Closed
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
– -$2.1K -120 Closed
1
2

MRTX Hedge Fund Activity: Q4 2014 in Review

44 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q4 2014, worth a combined $150M — up 6.7% from $140M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MRTX positions and 2 closed out — a net gain of 3 holders — while 14 added to existing stakes and 13 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $1.14M. The largest seller was Tang Capital Management, cutting an estimated $843K.

  • 44 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q4 2014, up from 43 in Q3 2014.
  • Funds reported $150M of Mirati Therapeutics, Inc. Common Stock stock for Q4 2014, up 6.7% quarter-over-quarter.
  • 5 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q4 2014 and 2 closed out, a net change of +3 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock buyer in Q4 2014 was Fidelity Investments, an estimated $1.14M added.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q4 2014 was Tang Capital Management, an estimated $843K sold.

Based on aggregated 13F filings for Q4 2014.